Company or ticker...

BioTech

Arcutis

Arcutis develops and commercializes innovative dermatology treatments focusing on immune-mediated skin diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

ARQT

2.9B

7.8

n/a

-18.59%

Key Facts

M. Cap

PS

PE

YTD

2.9B

7.8

n/a

-18.59%

10MA

20MA

50MA

200MA

$ARQT